Cargando…

Comparison of SUV(max) Values Obtained from F-18 FDG PET/CT and Cell-free DNA Levels Measured from Plasma in Oncology Patients

OBJECTIVES: The aim of this study was to compare the quantitative value of standardized uptake value (SUV) SUV(max) obtained from F-18 FDG positron emission tomography/computed tomography (PET/CT) imaging of oncology patients with the cell-free DNA (cfDNA) amounts measured in plasma of patients and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Çelik, Fatmanur, Tan, Yusuf Ziya, Özdemir, Semra, Sılan, Fatma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592314/ https://www.ncbi.nlm.nih.gov/pubmed/31234620 http://dx.doi.org/10.4274/mirt.galenos.2019.60352

Ejemplares similares

Prognostic Prediction of BRCA Mutations by (18)F-FDG PET/CT SUV(max) in Breast Cancer
por: Özdemir, Semra, et al.
Publicado: (2021)

Utility of SUV(max) on (18) F-FDG PET in detecting cervical nodal metastases
por: Lim, Rebecca S. M., et al.
Publicado: (2016)

Assessment of Mediastinal Tumors Using SUV(max) and Volumetric Parameters on FDG-PET/CT
por: Morita, Takahiro, et al.
Publicado: (2017)

Correlation of (18)F-FDG/PET SUV(max), SUV(mean), MTV, and TLG with HIF-1α in Patients with Colorectal Cancer
por: Kaymak, Zümrüt Arda, et al.
Publicado: (2021)

Prognostic value of nodal SUV(max) of (18)F-FDG PET/CT in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
por: Lee, So Jung, et al.
Publicado: (2017)

Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor
por: Zwezerijnen, Gerben J. C., et al.
Publicado: (2022)

Assessment of Heart Rate Recovery with GATED-Myocardial Perfusion Scintigraphy Outcome in Patients with Coronary Artery Disease: A Retrospective Study and Institutional Experience
por: Tan, Yusuf Ziya, et al.
Publicado: (2016)

FDG PET using SUV(max) for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapy
por: Huang, Yung-Cheng, et al.
Publicado: (2017)

(18)F-FDG PET/CT SUV(max) and serum CEA levels as predictors for EGFR mutation state in Chinese patients with non-small cell lung cancer
por: Gao, Xi-Can, et al.
Publicado: (2020)

FDG Dose Extravasations in PET/CT: Frequency and Impact on SUV Measurements
por: Osman, Medhat M., et al.
Publicado: (2011)

The correlation of expression of VEGF and EGFR with SUV of (18)FDG-PET-CT in non-small cell lung cancer
por: Liu, Xiguang, et al.
Publicado: (2014)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

Risk stratiﬁcation using gated stress myocardial perfusion imaging: comparison between patients with and without sexual dysfunction
por: Tan, Yusuf Ziya, et al.
Publicado: (2016)

Does Measurement of First-Order and Heterogeneity Parameters Improve Response Assessment of Bone Metastases in Breast Cancer Compared to SUV(max) in [(18)F]fluoride and [(18)F]FDG PET?
por: Azad, Gurdip K., et al.
Publicado: (2018)

Relation between nodule size and (18)F-FDG-PET SUV for malignant and benign pulmonary nodules.
por: Khalaf, Majid, et al.
Publicado: (2008)

Deformation Effect on SUV(max) Changes in Thoracic Tumors Using 4-D PET/CT Scan
por: Huang, Tzung-Chi, et al.
Publicado: (2013)

Association Between (18)F-FDG PET/CT-Based SUV Index and Malignant Status of Persistent Ground-Glass Nodules
por: Niu, Rong, et al.
Publicado: (2021)

Calculating an estimate of tissue integrated activity in (18)F-FDG PET imaging using one SUV value
por: Laffon, Eric, et al.
Publicado: (2013)

Integrated (18)FDG PET/CT: Utility and Applications in Clinical Oncology
por: Pinilla, Inmaculada, et al.
Publicado: (2008)

A convolutional neural network for fully automated blood SUV determination to facilitate SUR computation in oncological FDG-PET
por: Nikulin, Pavel, et al.
Publicado: (2020)

For avid glucose tumors, the SUV peak is the most reliable parameter for [(18)F]FDG-PET/CT quantification, regardless of acquisition time
por: Sher, Avigaëlle, et al.
Publicado: (2016)

FDG-PET staging and importance of lymph node SUV in head and neck cancer
por: Kubicek, Gregory J, et al.
Publicado: (2010)

Normal SUV Values Measured from NaF18- PET/CT Bone Scan Studies
por: Win, Aung Zaw, et al.
Publicado: (2014)

Quantitative techniques in (18)FDG PET scanning in oncology
por: Castell, F, et al.
Publicado: (2008)

When SUV Matters: FDG PET/CT at Baseline Correlates with Survival in Soft Tissue and Ewing Sarcoma
por: Hack, Ruben I., et al.
Publicado: (2021)

Textural features and SUV-based variables assessed by dual time point 18F-FDG PET/CT in locally advanced breast cancer
por: Garcia-Vicente, Ana María, et al.
Publicado: (2017)

18F-FDG PET/CT scan standardised uptake value (SUV) score for diagnosis, staging and monitoring malignancy in spinal melanotic schwannoma
por: Haleem, Shahnawaz, et al.
Publicado: (2022)

The impact of infection and inflammation in oncologic (18)F-FDG PET/CT imaging
por: Rahman, W. Tania, et al.
Publicado: (2019)

What and how should we measure in paediatric oncology FDG-PET/CT? Comparison of commonly used SUV metrics for differentiation between paediatric tumours
por: Blautzik, Janusch, et al.
Publicado: (2019)

SUV(fdg): A standard-uptake-value (SUV) body habitus normalizer specific to fluorodeoxyglucose (FDG) in humans
por: Beattie, Bradley J., et al.
Publicado: (2022)

Exploration of the threshold SUV for diagnosis of malignancy using (18)F-FBPA PET/CT
por: Isohashi, Kayako, et al.
Publicado: (2022)

Interobserver variability of image-derived arterial blood SUV in whole-body FDG PET
por: Hofheinz, Frank, et al.
Publicado: (2019)

Application of FDG-PET/CT in Radiation Oncology
por: Li, Jun, et al.
Publicado: (2013)

Appropriateness criteria of FDG PET/CT in oncology
por: Agrawal, Archi, et al.
Publicado: (2015)

The value on SUV-derived parameters assessed on (18)F-FDG PET/CT for predicting mediastinal lymph node metastasis in non-small cell lung cancer
por: Liao, Xuhe, et al.
Publicado: (2023)

Effect of COVID-19 on (18)F-FDG PET/CT: Is There a Need to Consider COVID-19 Status Before Planning (18)F-FDG PET/CT for Oncologic Evaluation?
por: Kavanal, Anwin Joseph, et al.
Publicado: (2021)

(18)F-FDG PET/CT Findings of Leptomeningeal Metastasis in Nasopharyngeal Carcinoma
por: Montanarella, Matthew, et al.
Publicado: (2023)

Cardiac and Pericardial (18)F-FDG Uptake on Oncologic PET/CT: Comparison with Echocardiographic Findings
por: Yi, Jeong-Eun, et al.
Publicado: (2018)

Follow-up (18)F-FDG PET/CT in an oncological asymptomatic COVID-19 patient()
por: López-Mora, D.A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6uvokrddjsvlgij65flarrhe1f